Target intelligence / Profile preview

Retinoschisin Protein (RS1)

Target
RS1
Molecular classification
Cell adhesion molecule, Lectin
01

Overview

Retinoschisin (RS1) is a soluble, cell-surface lectin crucial for retinal structure and function. Encoded by the RS1 gene on chromosome Xp22.13, it is specifically expressed in photoreceptor and bipolar cells of the retina, as well as pinealocytes. The protein contains a discoidin domain and forms oligomeric structures (homo16mer) that facilitate strong membrane adhesion between retinal cells. RS1 acts as an extracellular cell adhesion molecule, binding to plasma membranes of photoreceptors and bipolar cells and interacts with Na/K ATPase complexes (α3/β2 isoforms). Mutations in RS1 cause X-linked juvenile retinoschisis, leading to retinal splitting and progressive vision loss. Key interacting partners include Na/K ATPase and SARM1, which are important for maintaining retinal tissue integrity and regulating intracellular signaling.

Other names
X-linked juvenile retinoschisis proteinXLRS1XLRS1_HUMAN
02

Mechanism of action

Currently, no drugs directly target RS1. Gene therapy approaches are under investigation.

03

Biological functions

Cell-cell adhesionMaintenance of retinal structureSynaptic structure maintenanceModulation of intracellular signaling
04

Disease associations

X-linked juvenile retinoschisisMacular degeneration
05

Safety considerations

Potential immunogenicity of gene therapy vectorsOff-target effects of gene editing technologies

Beyond the preview

Go deeper on Retinoschisin Protein (RS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoschisin Protein (RS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call